Chronic Myeloid Leukemia: Symptoms, Causes, Treatment

It may be found through an elevated white-cell count before symptoms appear. Chronic does not mean follow-up can be neglected; disease phase and molecular response guide specialist care.

Related reading: Distinguishing chronic lymphocytic leukemia.

Fatigue, night sweats, weight loss, early fullness or discomfort under the left ribs from an enlarged spleen may occur. Some people remain symptom-free despite abnormal blood counts.

An acquired BCR::ABL1 fusion, usually associated with the Philadelphia chromosome, develops in a blood cell and promotes growth. This change is generally not inherited from a parent.

Increasing age and substantial radiation exposure increase risk; males are affected slightly more often. Many people have no identifiable trigger, and diagnosis does not imply an inherited family cancer.

Diagnosis uses blood counts and fusion-gene testing in blood or marrow, with marrow and phase assessment when indicated. Repeated molecular measurements monitor response beyond blood counts alone.

BCR::ABL1-targeted tyrosine kinase inhibitors are commonly used. Selection depends on disease phase, coexisting illness and response. Stem cell transplantation is reserved for selected circumstances rather than every patient.

Disease may progress to a more aggressive phase or cause anemia, bleeding or infection. Medicines have different adverse effects requiring monitoring and adjustment rather than unsupervised discontinuation.

There is no established prevention. Follow medication and testing schedules and discuss interactions or pregnancy. Treatment discontinuation is considered only under defined specialist criteria and close monitoring.